ConductScience.org, home

Paper36768432

Natural Killer Cell-Based Immunotherapy against Glioblastoma.

Morimoto T and 5 others. Int J Mol Sci, 2023. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Natural Killer Cell-Based Immunotherapy against Glioblastoma. Papers, record 36768432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768432

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural Killer Cell-Based Immunotherapy against Glioblastoma.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
3.67
iCite
Revised in PubMed
2023-02-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morimoto TTakayukihttps://orcid.org/0000-0002-9974-3538
2Nakazawa TTsutomuhttps://orcid.org/0000-0003-4286-9356
3Maeoka RRyosuke
4Nakagawa IIchirohttps://orcid.org/0000-0002-1340-3293
5Tsujimura TTakahiro
6Matsuda RRyosukehttps://orcid.org/0000-0002-0307-3657

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Brain NeoplasmsMajor topic
Adult
Humans
Immunotherapy
Killer Cells, Natural
Immunotherapy, Adoptive
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22K16667a Grand-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of JapanPubMed

Source PubMed

Download CSV of grants

References213

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127221712Dephosphorylation of the adaptor LAT and phospholipase C-γ by SHP-1 inhibits natural killer cell cytotoxicity.Sci Signal2016https://conductscience.org/library/papers/27221712PubMed
230666307Engineering and Design of Chimeric Antigen Receptors.Mol Ther Methods Clin Dev2019https://conductscience.org/library/papers/30666307PubMed
328486109Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Cancer Cell2017https://conductscience.org/library/papers/28486109PubMed
430224810CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature.Nat Neurosci2018https://conductscience.org/library/papers/30224810PubMed
525584137Autologous therapies in dermatology.J Clin Aesthet Dermatol2014https://conductscience.org/library/papers/25584137PubMed
629385370Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29385370PubMed
731409707Enhanced adaptive immune responses in lung adenocarcinoma through natural killer cell stimulation.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31409707PubMed
832826231Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia.Cancer Discov2020https://conductscience.org/library/papers/32826231PubMed
934836966Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma.Nat Commun2021https://conductscience.org/library/papers/34836966PubMed
1026806484Natural killer cell memory in infection, inflammation and cancer.Nat Rev Immunol2016https://conductscience.org/library/papers/26806484PubMed
1122854781A restricted cell population propagates glioblastoma growth after chemotherapy.Nature2012https://conductscience.org/library/papers/22854781PubMed
1230702189Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.Cancer Sci2019https://conductscience.org/library/papers/30702189PubMed
1329435173CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes.Oncotarget2018https://conductscience.org/library/papers/29435173PubMed
149730896Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.J Exp Med1998https://conductscience.org/library/papers/9730896PubMed
1530840664Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.PLoS One2019https://conductscience.org/library/papers/30840664PubMed
1635864254Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med2022https://conductscience.org/library/papers/35864254PubMed
1729497427Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.Front Immunol2018https://conductscience.org/library/papers/29497427PubMed
1820147410NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus.J Virol2010https://conductscience.org/library/papers/20147410PubMed
1928426845HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.JAMA Oncol2017https://conductscience.org/library/papers/28426845PubMed
2032457755Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.Front Immunol2020https://conductscience.org/library/papers/32457755PubMed

See all 213 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42940171Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells.Biomedicines2026https://conductscience.org/library/papers/42940171PubMed
42652153Challenges and Opportunities of γδ T Cell-Based Immunotherapy for Glioblastoma.Biomedicines2026https://conductscience.org/library/papers/42652153PubMed
42540549Chromosomal instability is associated with paradoxical cGAS upregulation and impaired STING signaling shaping the immune microenvironment in glioblastoma.Neurooncol Adv2026https://conductscience.org/library/papers/42540549PubMed
42465775The immunosuppressive tumor microenvironment in glioblastoma.Front Immunol2026https://conductscience.org/library/papers/42465775PubMed
41998834Natural Product 4-Acetylantroquinonol B Enhances NK Cell-Mediated Immunity Against Glioblastoma.Cancer Med2026https://conductscience.org/library/papers/41998834PubMed
41929521Natural killer cell dysfunction in glioma: from immune evasion to immunotherapy.Front Immunol2026https://conductscience.org/library/papers/41929521PubMed
41929516Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma.Front Immunol2026https://conductscience.org/library/papers/41929516PubMed
41913181Glioblastoma-natural killer cell crosstalk: insights from dynamic spheroid models reveal the importance of secreted cytokines and the CD155 axis.Cell Commun Signal2026https://conductscience.org/library/papers/41913181PubMed
41601660Natural killer cell-based senotherapy: a promising strategy for healthy aging.Front Immunol2025https://conductscience.org/library/papers/41601660PubMed
41463154Cell-Surface PCNA Is Co-Expressed with Biomarkers of Stemness and Immunosuppression in Glioblastoma.Cancers (Basel)2025https://conductscience.org/library/papers/41463154PubMed
41403931Shaping the glioblastoma microenvironment to enhance CAR-NK immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41403931PubMed
41179878The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology.Front Med (Lausanne)2025https://conductscience.org/library/papers/41179878PubMed
41030289Cell therapies against brain tumors: Clinical development and emerging prospects.Bioeng Transl Med2025https://conductscience.org/library/papers/41030289PubMed
40974256Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma.Neuro Oncol2026https://conductscience.org/library/papers/40974256PubMed
40924328Photodynamic therapy for glioblastoma: a narrative review.J Neurooncol2025https://conductscience.org/library/papers/40924328PubMed
40696929Immunotherapy in central nervous system tumors.Int J Surg2025https://conductscience.org/library/papers/40696929PubMed
40628732Glioblastoma at the crossroads: current understanding and future therapeutic horizons.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40628732PubMed
40426086The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors.BMC Cancer2025https://conductscience.org/library/papers/40426086PubMed
40352591Expanding horizons of cancer immunotherapy: hopes and hurdles.Front Oncol2025https://conductscience.org/library/papers/40352591PubMed
39669560
A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence.
Front Immunol2024https://conductscience.org/library/papers/39669560PubMed

See all 34 cited byDownload CSV of cited by

Genes94

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADAM176868PubTator's text mininghttps://conductscience.org/library/genes/6868NCBI Gene
BAG1573PubTator's text mininghttps://conductscience.org/library/genes/573NCBI Gene
BAG67917PubTator's text mininghttps://conductscience.org/library/genes/7917NCBI Gene
CARS1833PubTator's text mininghttps://conductscience.org/library/genes/833NCBI Gene
CBLB868PubTator's text mininghttps://conductscience.org/library/genes/868NCBI Gene
CCL36348PubTator's text mininghttps://conductscience.org/library/genes/6348NCBI Gene
CCL46351PubTator's text mininghttps://conductscience.org/library/genes/6351NCBI Gene
CCL56352PubTator's text mininghttps://conductscience.org/library/genes/6352NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD22610666PubTator's text mininghttps://conductscience.org/library/genes/10666NCBI Gene
CD24451744PubTator's text mininghttps://conductscience.org/library/genes/51744NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD9610225PubTator's text mininghttps://conductscience.org/library/genes/10225NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CEACAM1634PubTator's text mininghttps://conductscience.org/library/genes/634NCBI Gene

See all 94 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36768432

GET https://conductscience.org/api/papers/v1/36768432/references?page=2